| abstract |
The present invention relates to anti-HIV antibodies. Related methods and compositions are also disclosed. HIV causes Acquired Immune Deficiency Syndrome (AIDS), a human condition characterized by clinical features including wasting syndrome, central nervous system degeneration and leading to life-threatening opportunistic infections and malignant including severe immunosuppression. Since its discovery in 1981, HIV-1 (HIV‑1) has killed at least 25 million people worldwide. |